ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/4/2023ACC: 0001209191-23-051960
Officer· Interim CFO
Since Jun 2021
-1.09K
Net shares
Net seller
$4.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.09K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.09K
Price / share
$3.83
Trade value
$4.16K
% of position
13.6%
10/2/2023
8.02K→6.93K
Total
Net shares
−1.09K
Net value
-$4.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2023 | F · Tax Withholding | −1.09K | $3.83 | $4.16K | 13.6% | 8.02K | 6.93K |
| Total | −1.09K | -$4.16K | ||||||
Derivative Transactions0
No derivative transactions reported